Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal

benzinga.com/m-a/25/11/48870663/lundbecks-higher-buyout-proposal-challenges-alkermes-pending-2-billion-avadel-deal

Avadel Pharmaceuticals plc (NASDAQ:AVDL) on Friday received an unsolicited proposal from H. Lundbeck A/S for up to $23.00 per ordinary share.
AVDL is reaching significant price levels. See if it is worth your attention here
The deal consideration includes $21 per share in cash and a…

This story appeared on benzinga.com, 2025-11-14 16:37:57.
The Entire Business World on a Single Page. Free to Use →